Biopharma money raised to-date and by month in 2026, including public, private and other financings. Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing Cookie ...

Year-to-date money raised in public, private and other financings of biopharma companies. Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing Cookie Settings ...

South San Francisco-based Trex Bio Inc. priced its IPO of about 8.3 million shares at $14 per share for about $116.7 million to finance efforts taking aim at a pair of targets hardly unfamiliar to the ...

The drumbeat of innovation in the heart valves space continues as companies pursue next-generation devices for easier implantation, to improve durability and to treat younger patients. Even though ...

Viatris Inc. plans to discuss the buyout of Pacira Biosciences Inc. during its third-quarter earnings call Nov. 5, but the ...

Ono Pharmaceutical Co. Ltd. is paying $100 million up front to gain select Asian rights to Biohaven Ltd.’s small-molecule IgG degrader portfolio, including in Japan, South Korea and Taiwan, as it ...

Neurizon Therapeutics Ltd. has advanced NUZ-001 (monepantel) from a 12-patient proof-of-concept study into a fully enrolled, ...

Several initiatives the U.S. Department of Health and Human Services (HHS) announced Oct. 8 continue to shift the government’s vaccine focus from disease prevention to vaccine harm. Strengthening “how ...

In the last five years, public markets in Europe have been a no-go area for biotechs, and for U.K. companies the situation is dire, with the way barred to new entrants and a lack of liquidity leading ...

Vinci Pharmaceuticals Inc. has closed a series A financing round raising over $8 million as the company advances development of its Epiplant delivery platform.

A team of researchers from The Ottawa Hospital Research Institute shed some light on a potential association between the ...

Huadong Medicine presented data for DD-1013, a novel long-acting GLP-1/GIP/amylin receptor triple agonist that was tested in vitro and in vivo for obesity management in diet-induced obese rats.